giant multinucleated cells (25) , typically associated with granuloma structures. Finally, IL-6 has been described to stimulate the tuberculostatic functions of murine bone-marrow-derived macrophages (11) . Mosmann influences the outcome of the infection. Thus, susceptible BALB/c mice mount a strong TH2 type of response during infection with the protozoal parasite, whereas resistant C57BL/6 (B6) mice activate preferentially their TH1 compartment (17) .
Two articles have recently reported the activation of different T-helper subsets in tuberculoid and lepromatous leprosy in humans. First, mycobacterium-reactive T-cell clones derived from tuberculoid leprosy patients were found to exhibit a TH1-like cytokine secretion pattern, with very high levels of IFN-y and low levels of and IL-5 (15) . Second, Yamamura et al. (45) found that different cytokine mRNA profiles were present in leprosy skin lesions, depending on the severity of the disease. Thus, in paucibacillary lesions from tuberculoid leprosy, mRNAs coding for IL-2 and IFN--y were most evident, whereas in multibacillary lesions from lepromatous leprosy, mRNA for IL-4 and IL-10 predominated (45) .
We previously reported that mouse strains show a marked genetic variation in the amount of IFN-y produced after intravenous infection with live Mycobacterium bovis BCG. Thus, BCG-infected BALB/c mice produce fourfold less IFN--y when stimulated in vitro with purified protein derivative (PPD) or with the purified 32-kDa fibronectin-binding culture filtrate (CF) protein (also called P32 or antigen 85A) than B6 mice do (20) . In this study, we (35) . Mean fluorescence intensities were determined by using a fluorescenceactivated cell sorter (FACStar-plus; Becton Dickinson). A titration curve was constructed with recombinant murine IL-4 (from methotrexate-amplified CHO cells, kindly provided by W. Fiers and P. Vandenabeele, Laboratory of Molecular Biology, Rijksuniversiteit te Gent, Ghent, Belgium) ranging from 0.01 to 10 U/ml, and the IL-4 content of supernatants was expressed in units per milliliter. The anti-IL-4 MAb llB1l always inhibited the increase in class II MHC expression by more than 90%, indicating that only IL-4 was responsible for this activity.
IL-5 assay. IL-5 activity was measured in an enzymelinked immunosorbent assay (ELISA), using the TRFK5 and TRFK4 anti-IL-5 MAbs, generously provided by R. Coffman (38) . Briefly, ELISA plates were coated overnight with TRFK5 (1:2,000), washed, and blocked with bovine serum albumin. Next, culture supernatant was added overnight, and, after washing, the second MAb (TRFK4 [IgG2a]) was added. Finally, the enzymatic reaction was developed by using a peroxidase-conjugated rat anti-mouse IgG2a, OPD (chromogen), and H202.
IL-6 assay. IL-6 activity was assessed in a colorimetric assay by measuring hexose-aminidase levels of 7TD-1 mouse-mouse hybridoma cell cultures grown in the absence or presence of serial fivefold dilutions of culture supernatants (21 (40) and in view of the substantial IL-6 levels found in these culture supernatants (see below), we also examined the effect of E. coli-derived recombinant human We have previously reported that spleen cells from BCG-infected BALB/c mice produce four times less IFN-y in response to PPD and the purified 32-kDa antigen (antigen 85A) than spleen cells from B6 or BALB.B10 mice (20) . As shown in Table 2 , B6 and BALB.B10 spleen cells also produced more IFN--y than BALB/c cells did in response to whole CF. Lower IFN--y titers were found after stimulation with BCG extract or whole BCG, and the titers were more or less similar for the three strains. In contrast, the 65-kDa Hsp induced higher IFN--y titers in spleen cells from BALB/c and BALB.B10 mice than in those from B6 mice. The IFN detected in antigen-stimulated culture supernatants was characterized as genuine IFN--y because 90 to 95% of its antiviral activity could be neutralized by using the potent MAb F3 directed specifically against murine IFN--y (18). Furthermore, supernatants from unstimulated BALB.B10 spleen cells contained substantial amounts of spontaneously produced IFN, which was characterized as 100% acid-stable IFN-ao/1 (data not shown).
IL-4 production in spleen cell cultures. It was first verified that the various antigenic preparations did not interfere as such with the IL-4 assay (data not shown). Preliminary experiments indicated that IL-4 activity peaked in spleen cell cultures after 72 h. Unstimulated BALB/c spleen cells produced significant amounts of IL-4, and antigenic stimulation increased these levels. IL-4 titers were highest in response to whole CF (Table 3 ). In contrast, no IL-4 activity was found in spleen cell supernatants from B6 or BALB.B10 mice. The activity measured in the supernatants was genuine IL-4 because the enhancing effect on Ia expression could be completely abrogated with MAb llB1l (rat IgGl anti-IL-4). IL-5 production in spleen cell cultures. By using an immunoenzymatic assay with the TRFK4 and TRFK5 anti-IL-5 MAbs (38), IL-5 could not be detected in any of the culture supernatants tested 4 weeks after primary BCG infection.
IL-6 production in spleen cell cultures. Significant levels of IL-6 were detected in spleen cell culture supernatants from BCG-infected mice ( Table 4 ). The growth activity was characterized as genuine IL-6 because it could be neutralized completely by the anti-IL-6 MAb 6B4 (42) (a kind gift of J. Van Snick). We previously reported that non-T cells are the main IL-6-producing cells in BCG-infected mice (21) . All three strains produced substantial amounts of IL-6. In BALB/c cells, maximal production was induced with whole BCG and BCG extract, whereas little IL-6 was induced with PPD and CF. In B6 and BALB.B10 cultures, on the other hand, PPD and CF were potent IL-6 inducers. Interestingly, stimulation with the 30-32-kDa antigen also resulted in increased IL-6 levels in B6 and in BALB.B10 cells. LPS induced comparable IL-6 titers in the three mouse strains.
TNF-a production in spleen cell cultures. Elevated levels of TNF-ao were found in spleen cell culture supernatants from BCG-infected mice. The highest TNF-ot levels were obtained after stimulation with whole BCG or BCG extract, and these levels were comparable in all three strains. On the other hand, TNF-ot production in response to CF and PPD was two-to threefold higher in B6 and BALB.B10 cells than in BALB/c cells (Table 5) . Biological assays on TNF-sensitive L929 indicator cells failed to detect TNF activity in these supernatants, suggesting the presence of TNF inhibitors (40a) .
Bacterial proliferation in the spleen of BCG-infected mice. Bacterial proliferation, calculated from the number of BCG CFU found in the spleen 2, 4, 6, and 8 weeks after a primary infection with BCG, was comparable in the three mouse strains (Fig. la) . A marked difference was observed, however, in the development of protective immune memory during primary infection. In BCG-vaccinated B6 and BALB.B10 mice, a second BCG inoculum was eliminated more rapidly than the first inoculum, reflected by a 5-to 10-fold lower number of BCG CFU in the spleens of vaccinated mice compared with that in the spleens of primaryinfected mice (Fig. lb) . BCG vaccination in BALB/c mice was not effective, as CFU values in primary-infected and rechallenged mice were comparable. In some experiments, CFU values were even higher in vaccinated than in primaryinfected BALB/c mice.
DISCUSSION
Acquired protective immunity against mycobacteria is the result of interactions between specifically sensitized T cells and macrophages harboring the infectious organism. Little is known about the precise antigens involved in protective immunity against these pathogens, but living organisms have been reported to be more effective in the generation of specific acquired resistance than dead mycobacterial preparations (33) . An increasing number of authors have therefore argued that secreted antigens, present in large amounts in mycobacterial CFs, rather than intracellular components may be essential for the induction of protective immunity (2, 16, 34) .
In this article, we have analyzed cytokine production in response to secreted CF antigens and to whole BCG bacilli and BCG extract by spleen cells from three susceptible mouse strains infected intravenously with M. bovis BCG. B6 and BALB.B10 mice (both H-2b) were found to produce 5 These results are reminiscent of another infectious model, i.e., murine leishmaniasis, in which a clear dichotomy of T-cell response has been observed in BALB/c and B6 mice infected with the protozoal parasite L. major (17, 24) . Some fundamental differences between the two experimental systems must, however, be emphasized. Whereas the susceptibility to cutaneous leishmaniasis is clearly different for susceptible BALB/c and resistant B6 mice, BALB/c and B6 mice have similar susceptibilities to M. bovis BCG infection, both expressing the susceptible allele of the bcg gene (39) . Bacterial multiplication of the BCG vaccine is observed during the first weeks of infection, and later BCG is gradually eliminated, in both strains, by acquired cell-mediated immune effector mechanisms. In this article, we have described, however, striking differences in the development of long-term protective memory in these BCG-vaccinated mouse strains: B6 and BALB.B10 mice are capable of a rapid clearance of a second challenge inoculum of BCG 2 months after primary infection, whereas BALB/c mice eliminate this second inoculum at a rate no higher than the rate at which they eliminate the first infection.
Recently, Yamamura et al. analyzed cytokine profiles in leprosy skin biopsy specimens by polymerase chain reaction amplification of extracted mRNA (45) . In tuberculoid leprosy lesions, mRNAs for IL-2 and IFN--y were most evident, whereas in lepromatous leprosy lesions, mRNAs for IL-4 and IL-5 predominated. Interestingly, tuberculoid lesions also contained more TNF-ao and IL-6 mRNA and lepromatous lesions contained more IL-10. BCG-infected BALB/c mice, therefore, appear to have a spleen cell cytokine secretion pattern similar to that of lepromatous leprosy patients, whereas B6 and BALB.B10 cytokine profiles resemble those found in tuberculoid leprosy patients. Interestingly, in leprosy, human leukocyte antigen-linked genes have been reported to control not the susceptibility per se but the type of leprosy (41) .
Optimal proliferation of TH1 and TH2 subsets is thought to depend on distinct antigen-presenting cells and their respective costimulatory factors (13) . Moreover, amplification of the respective T-helper subsets is controlled by counterregulatory cytokines, TH2 proliferation being directly inhibited by the TH1 lymphokine IFN--y and cytokine secretion of TH1 cells being inhibited by the cytokine IL-10, probably via inhibition of monokine (IL-1, IL-6, TNF-a) secretion and class II MHC expression on antigen-presenting cells (9, 29) . We hypothesize that at the onset of BCG infection, extracellular CF components will elicit elevated production of IL-6 and TNF-ac in H-2b mice, which in turn will lead to TH1 activation, IFN--y secretion, increased IL-6 and TNF production by IFN-y-activated macrophages, and subsequent inhibition of IL-4 production by TI2 cells. In H-2d mice, on the other hand, CF antigens will stimulate antigen-presenting cells to a lesser extent, leading to lower IL-2 and IFN--y levels and resulting in substantial IL-4 production. Furthermore, high TH1 activity against CF antigens seems to correlate with protective immunity. Analysis of the cytokine secretion early during BCG infection could give us more insight into the mechanisms by which MHC genes exert this regulatory control.
